Form D · Biotechnology

Basking Biosciences, Inc.

Cary, NC · CIK 0001824142

Offering snapshot reported Oct 22, 2025 · SEC filing

Reported sold: $55M
Investors reported: 11
Minimum accepted: $0
First sale: Oct 31, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$27,500,017 → $55,000,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 22, 2025	Amendment	$55,000,000	$27,499,983vs Nov 15, 2023	11	SEC filing
Nov 15, 2023	Initial	$27,500,017	No comparison	11	SEC filing
Sep 10, 2020	Initial	$1,901,122	No comparison	6	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-497367

Source: Form D, filed Oct 22, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Aiden Aceves	Director
David Adair	Director
Hannah Chang	Director
Steve Gillis	Director
Ryan Helon	Director
Dan Myers	Director
Thomas Needham	Director
Shahid Nimjee	Director
Ari Nowacek	Director
Julia Owens	Director, Executive, Promoter
Richard Shea	Director, Executive, Promoter
Bruce Sullenger	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

964 High House Rd #3268
Cary, NC, 27513